[VRTX] QoQ Quarter Result on 30-Sep-2022 [#Q3]

Stock
[VRTX] Vertex Pharmaceuticals Incorporated
Announcement Date
28-Oct-2022
Financial Year
2022
Quarter
30-Sep-2022 [#Q3]
Profit Trend
QoQ- 14.81%
YoY- 9.22%
Quarter Report
VRTX's Result
VRTX's Financial Summary
View:
Show?
Quarter Result
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
Revenue 2,493,200 2,374,800 2,302,700 2,334,300 2,196,200 2,097,500 2,072,600 13.14%
PBT 1,161,500 891,500 1,076,800 1,176,400 1,024,400 954,800 870,900 21.22%
Tax 245,800 191,700 257,900 245,900 213,900 192,700 100,800 81.46%
NP 915,700 699,800 818,900 930,500 810,500 762,100 770,100 12.27%
Tax Rate -21.16% -21.50% -23.95% -20.90% -20.88% -20.18% -11.57% -
Total Cost 1,577,500 1,675,000 1,483,800 1,403,800 1,385,700 1,335,400 1,302,500 13.66%
Ratio Analysis
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
NP Margin 36.73 29.47 35.56 39.86 36.90 36.33 37.16 -0.77%
Per Share
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
EPS 3.55 2.72 3.19 3.63 3.17 2.99 3.02 11.41%
EPS Diluted 3.52 2.69 3.15 3.59 3.13 2.96 3.00 11.27%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.